trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.
about
Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagyMultiple Aspects of Gene Dysregulation in Huntington's DiseaseThe Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary FibrosisForever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegenerationSIRTain regulators of premature senescence and accelerated agingPGC-1α, mitochondrial dysfunction, and Huntington's diseaseFunction of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative diseaseRole of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesisMetabolism in HD: still a relevant mechanism?Sirtuins: guardians of mammalian healthspan.Sirtuins Function as the Modulators in Aging-related Diseases in Common or RespectivelyPGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionAtrazine exposure causes mitochondrial toxicity in liver and muscle cell lines.AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.Sirtuin 3: A major control point for obesity-related metabolic diseases?Sirtuin-3 (SIRT3) and the Hallmarks of Cancer.A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtinSirtuins in neurodegenerative diseases: an update on potential mechanisms.VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease.Mitochondrial SIRT3 Mediates Adaptive Responses of Neurons to Exercise and Metabolic and Excitatory ChallengesThe Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors.Sirtuin deacetylases in neurodegenerative diseases of aging.Pathways to decoding the clinical potential of stress response FOXO-interaction networks for Huntington's disease: of gene prioritization and context dependence.Neuroprotective effects of psychotropic drugs in Huntington's diseaseActivators of AMPK: not just for type II diabetes.Chemistry and Biology of Resveratrol-Derived Natural ProductsThe role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases.SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model.Hypoxia promotes AMP-activated protein kinase (AMPK) and induces apoptosis in mouse osteoblasts.AMPK in Neurodegenerative Diseases.Sirtuins Expression and Their Role in Retinal Diseases.Brain metabolism in health, aging, and neurodegeneration.The brain, sirtuins, and ageing.Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.Selective A2A receptor antagonist SCH 58261 modulates striatal oxidative stress and alleviates toxicity induced by 3-Nitropropionic acid in male Wistar rats.Towards an Understanding of Energy Impairment in Huntington's Disease Brain.Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death.Anti-inflammatory effect of oligostilbenoids from Vitis heyneana in LPS-stimulated RAW 264.7 macrophages via suppressing the NF-κB activation.
P2860
Q24307769-CADD94EF-936F-4A42-9F97-0594D6B345CDQ24605880-2B5BBE59-277D-40CC-9E56-DA4258BF478FQ26786969-FDB70FD7-5235-4F8A-8221-B2AF2B92D91EQ26825012-76D2F7C7-31B8-46C2-9E7B-CA300D122568Q26997358-FF12B391-E447-4476-B1AF-0AFFC74FAA03Q27001671-24EE42B5-56ED-40E5-9D6C-E3681A4F9BE2Q28068499-53E6196B-F96A-45C8-B85A-032A53CB6FAFQ28386202-8ADE38C1-0A05-41D6-8473-38981D639277Q28394301-D19078E5-88E6-43BC-AEE5-69C799725E36Q33831420-7C3E1B3A-05A9-4C16-9CCA-7B7448C10259Q36523200-9704731F-589F-4E8A-A272-0889B3E84864Q36602023-2B2502BC-C398-4F49-B82D-4CD34A2DFF19Q36614556-D9BF984C-233E-4CC9-A867-43947F00F9BBQ36780229-A2F7E1B8-527E-4957-806B-C0DDA00B3BB1Q37062840-ADB041F0-16BF-427C-BC0B-A62EF40F938AQ37131173-CFF1F69D-9ECD-4E2A-904A-DC4572188D52Q37150523-F008D57B-9D03-4611-AAE8-5D63252E9E64Q37153804-100C597C-0763-4DFB-A018-3CFC41D4DE71Q37196388-881F442F-331B-442F-8685-73E64397EFA9Q37223339-62D3B255-616A-4333-82F0-CC41C8937437Q37480232-29887683-8310-4FD2-9DE3-D925C041A20BQ37575502-5C9FE21C-F0E1-473A-802C-C7FC6A57C8CDQ38107677-A4D8FCC8-9661-4775-BAB0-E6FC412A7CEAQ38108128-CAA203E4-D4D8-421A-9022-C405E3491C1CQ38115523-2DBE2A89-F0CE-43F4-A60C-24E8E9C1D9A4Q38163877-16FE3516-6D82-4D90-A479-D66CABE9C094Q38243893-FEB766E6-CA92-463B-991A-71330A2C818AQ38401947-41077E67-B90D-4D6A-8524-1DA9C146FE73Q38532744-9B5DF681-FA23-47C8-82F3-2C6DDAEC4AD3Q38780130-BBD53122-1614-4185-BFFA-38C046F1AADCQ38851280-D4C4FDC9-5CCD-4FDC-8ABB-37102CB0D47FQ38998405-A0A5B180-551B-4E4B-ABA1-52CD95A1F280Q39135669-C3AC3D3C-E9CC-4785-9A78-83EA5B09FA0AQ39259780-4499805D-EAAE-4179-B1A8-4028A07A1D6DQ39313687-A55D4564-E59A-4728-9EBA-CC95620723E2Q45294879-AFB6D300-5B96-46D4-B646-9550B671A841Q46323118-81C6C983-4DFD-436C-A33D-0FA977007065Q47442924-CE031070-BDD6-49CF-9AEC-96C839E6065FQ47883352-8FBBB07E-377B-436A-A56A-50D8AEA62012Q50016786-20BF0966-E40A-4541-8321-093BC5956463
P2860
trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@ast
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@en
type
label
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@ast
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@en
prefLabel
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@ast
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@en
P2093
P2860
P356
P1476
trans-(-)-ε-Viniferin increase ...... models of Huntington Disease.
@en
P2093
Jinrong Fu
Katelyn Hotaling
Mali Jiang
Nicolas Arbez
Robert H Cichewicz
Serena A Hageman
Trevor K Ellis
P2860
P304
24460-24472
P356
10.1074/JBC.M112.382226
P407
P577
2012-05-30T00:00:00Z